Vivacta Bio closes over 50 mln in Series A A financing
SHANGHAI, April 29, 2026 /PRNewswire/ — Vivacta Biotechnology (Shanghai) Co., Ltd. (“Vivacta” or “Vivacta Bio”), an innovative biotechnology company focused on revolutionizing in vivo CAR-T...
Category Added in a WPeMatico Campaign

